These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6461066)

  • 1. [[Clodronate therapy of hypercalcemia caused by hyperparathyroidism].
    Hoffmeyer P; Groebli Y; Spiliopoulos A; Jung A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):118-20. PubMed ID: 6461066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol].
    Scharla SH; Minne HW; Sattar P; Mende U; Blind E; Schmidt-Gayk H; Wüster C; Ho T; Ziegler R
    Dtsch Med Wochenschr; 1987 Jul; 112(28-29):1121-5. PubMed ID: 2956079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clodronate in the medical management of hyperparathyroidism.
    Hamdy NA; Gray RE; McCloskey E; Galloway J; Rattenbury JM; Brown CB; Kanis JA
    Bone; 1987; 8 Suppl 1():S69-77. PubMed ID: 2961358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME
    N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preoperative normalization of hypercalcemia, caused by parathyroid cancer, by intravenous administration of dichloromethylene diphosphonate].
    Conte N; Di Virgilio R; Roiter I
    Minerva Endocrinol; 1984; 9(1):47-8. PubMed ID: 6239086
    [No Abstract]   [Full Text] [Related]  

  • 7. Mineralization defect but no effect on hypercalcemia during clodronate treatment in secondary hyperparathyroidism.
    Ring T; Sodemann B; Nielsen C; Melsen F; Kornerup HJ
    Clin Nephrol; 1995 Sep; 44(3):209-10. PubMed ID: 8556838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttraumatic parathyroid crisis and severe hypercalcemia treated with intravenous bisphosphonate (APD). Case report.
    Canivet JL; Damas P; Lamy M
    Acta Anaesthesiol Belg; 1990; 41(1):47-50. PubMed ID: 2360392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
    Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS
    Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monotherapy with clodronate for tumor-induced hypercalcemia].
    Harjung H; Fritze D
    Dtsch Med Wochenschr; 1990 Jan; 115(2):48-52. PubMed ID: 2136827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Suppression of severe hypocalcemia associated with malignant lymphoma by intravenous administration of dichloromethylene diphosphonate].
    Tschopp JM; Jung A; Miescher PA
    Schweiz Med Wochenschr; 1981 Oct; 111(44):1655-7. PubMed ID: 6458087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of malignant hypercalcaemia with clodronate.
    Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
    Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC; Meunier PJ; Alexandre CM; Vignon EP
    J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with clodronate in patients with hypercalcemia secondary to malignancy.
    Lind L; Wengle B; Ljunghall S
    Ups J Med Sci; 1987; 92(3):259-63. PubMed ID: 2966487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
    Shane E; Jacobs TP; Siris ES; Steinberg SF; Stoddart K; Canfield RE; Bilezikian JP
    Am J Med; 1982 Jun; 72(6):939-44. PubMed ID: 6211978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis].
    Han GY; Wang O; Xing XP; Meng XW; Lian XL; Guan H; Ye W; Xia WB; Li M; Jiang Y; Hu YY; Liu HC; Cui QC
    Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):729-33. PubMed ID: 20079207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neoplastic hypercalcemia with renal insufficiency: treatment with dichloromethylene diphosphonate].
    Conte N; Di Virgilio R; Roiter I; Foscolo G; Baruffi C
    Clin Ter; 1985 Nov; 115(3):177-80. PubMed ID: 2935356
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma.
    Vega EM; Mautalen CA
    Medicina (B Aires); 1991; 51(2):106-10. PubMed ID: 1820495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of intravenous dichloromethylene diphosphonate in paraneoplastic hypercalcemia resistant to mithramycin].
    Peyron R; Sereni D; Grateau G; Boissonnas A; Cremer GA; Laroche C
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):435-7. PubMed ID: 6238399
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
    Delmas P; Chapuy MC; Vignon E; Briançon D; Charhon S; Meunier PJ
    Nouv Presse Med; 1982 Apr; 11(19):1471-4. PubMed ID: 6210878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.